Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier.
about
The Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to BrainPhysiology and pathophysiology of the blood-brain barrier: P-glycoprotein and occludin trafficking as therapeutic targets to optimize central nervous system drug deliveryPain management in patients with dementiaOral Triphenylmethane Food Dye Analog, Brilliant Blue G, Prevents Neuronal Loss in APPSwDI/NOS2-/- Mouse Model.Agile delivery of protein therapeutics to CNSChAT-positive neurons participate in subventricular zone neurogenesis after middle cerebral artery occlusion in mice.Development and characterization of glutathione-conjugated albumin nanoparticles for improved brain delivery of hydrophilic fluorescent marker.Safety and pharmacological characterization of the molecular tweezer CLR01 - a broad-spectrum inhibitor of amyloid proteins' toxicity.Polysialic acid as an antigen for monoclonal antibody HIgM12 to treat multiple sclerosis and other neurodegenerative disorders.Pramipexole-Induced Hypothermia Reduces Early Brain Injury via PI3K/AKT/GSK3β pathway in Subarachnoid Hemorrhage ratsNanoparticle transport across the blood brain barrier.Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease.Metabolic Dysfunction of Astrocyte: An Initiating Factor in Beta-amyloid Pathology?Adjusting the compass: new insights into the role of angiogenesis in Alzheimer's diseaseInteractive association of drugs binding to human serum albumin.Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights.Nanotherapeutic strategies for the treatment of Alzheimer's disease.A human anti-polysialic acid antibody as a potential treatment to improve function in multiple sclerosis patients.Improving drug delivery technology for treating neurodegenerative diseases.Critical review evaluating the pig as a model for human nutritional physiology.Albumin nanostructures as advanced drug delivery systems.Emerging amyloid and tau targeting treatments for Alzheimer's disease.Timosaponin B-II ameliorates scopolamine-induced cognition deficits by attenuating acetylcholinesterase activity and brain oxidative damage in mice.Altered brain uptake of therapeutics in a triple transgenic mouse model of Alzheimer's disease.Antibody blood-brain barrier efflux is modulated by glycan modification.Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future.Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood-brain barrier
P2860
Q26745586-61754AFD-F765-4EF7-91C4-D33C4423A30CQ26861408-9880099C-B0D6-4749-BBEE-7DDE3635AE91Q27024015-C01ECD51-7843-4848-BA08-9175FB7BC51CQ30277388-E1DF056B-E080-4DFE-A73D-AE483074E69BQ34079647-70D14DA1-E741-4F19-B349-399F4436035AQ34539893-994FA1EB-3D1F-45C4-A33B-F3A6B7E5AC4DQ34756512-1699835F-8942-4B30-A660-D479FCFB34AAQ35148785-AFAA0CF3-91BB-40F4-BF44-0FC3F1A6FF4CQ35940683-C25E1328-1C47-4D02-A2A8-5C631F14A016Q36741514-C9DB5347-128F-4BCE-84AE-8C5D4EDB2147Q36812347-9B537D5A-C4F0-4B9F-BD05-EB4B66C2F524Q37216153-EA7EAB90-5FDB-48C9-98E3-E353AD3FC49AQ37478957-037E1849-E305-4FC0-B821-788A4B6C96AFQ38172335-808F2104-32B2-4909-8020-3D27E22E5478Q38192435-D42D12C4-59BA-4297-BB17-8C7DD1F1770EQ38260539-55B136FF-04A5-464A-BF46-2D1FF26BB8C0Q38358865-9EBBD3EE-8486-4FA9-8ECF-6483F6B34BBFQ38406595-927FC7D7-8A62-45FD-B05F-F129323F7947Q38769989-D112D18B-57C0-418C-A805-BB563E411AA8Q38833748-98A6B6D2-EF7A-4FDD-BC42-6549BD0D384CQ38842596-444F050A-3A50-4D1C-BD85-923484B580D7Q39296311-9661A690-D632-4297-80F1-722135A6F07BQ39574447-55C42489-221E-4A2C-A0EE-304C5741ED7FQ43707054-C5809A70-D6CA-4C66-B95D-AF359DBA376EQ46348633-A4A885FA-9293-4BC7-88C2-229EF22F733DQ55364364-91E5DA15-6367-44B9-85EF-78229C542746Q57810063-94F75D61-9558-4DD9-94B7-8F0AB395E291
P2860
Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Drug delivery to the brain in ...... on of the blood-brain barrier.
@en
Drug delivery to the brain in ...... on of the blood-brain barrier.
@nl
type
label
Drug delivery to the brain in ...... on of the blood-brain barrier.
@en
Drug delivery to the brain in ...... on of the blood-brain barrier.
@nl
prefLabel
Drug delivery to the brain in ...... on of the blood-brain barrier.
@en
Drug delivery to the brain in ...... on of the blood-brain barrier.
@nl
P2860
P921
P1476
Drug delivery to the brain in ...... on of the blood-brain barrier.
@en
P2860
P304
P356
10.1016/J.ADDR.2011.12.005
P407
P577
2011-12-17T00:00:00Z